Articles From: 2014/2/10 - Sarepta Therapeutics Announces Positive Safety Results from Phase I Clinical Study of Marburg Drug Candidate to 2014/2/10 - Bard to Present at Citi 2014 Global Healthcare Conference


2014/2/10
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today announced positive safety results from a Phase I multiple ascending dose study of AVI-7288 in healthy volunteers.
Sign-up for 2014/2/10 - Sarepta Therapeutics Announces Positive Safety Results from Phase I Clinical Study of Marburg Drug Candidate investment picks
2014/2/10
CommScope, Inc., a global leader in infrastructure solutions for communications networks, now offers its hydrogen fuel cell solution to provide reliable backup power for small-to-medium enterprises in North America.
Sign-up for 2014/2/10 - CommScope Offers Outdoor Hydrogen Backup Power Solution For Businesses investment picks
2014/2/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1088479&ProfileId=051205&sourceType=1 TAMPA, FL --
Sign-up for 2014/2/10 - Enviro-Serv, Inc. Announces Aggressive Pest Control Subsidiary Expansion Through Large Acquisitions and Contract Purchases investment picks
2014/2/10
ACI Worldwide, Inc. (NASDAQ: ACIW), a leading international provider of electronic payment and banking systems , today announced preliminary unaudited financial results for the fourth quarter ended December 31, 2013.
Sign-up for 2014/2/10 - ACI Worldwide, Inc. Announces Preliminary Results for Fourth Quarter 2013 investment picks
2014/2/10
http://media.marketwire.com/attachments/201107/5119_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1088463&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for 2014/2/10 - PLX Technology's PCI Express-to-USB Solution Selected by Acer for New Aspire Z3-600 All-in-One Computers investment picks
2014/2/10
GUMI, South Korea and GREENSBORO, N.C., Feb.
Sign-up for 2014/2/10 - RFMD Earns Samsung's Quality Grand Award as Best Quality Supplier investment picks
2014/2/10
Smiths Medical, a leading global medical device manufacturer, announced today that its Portex Bivona FlexTend ™ TTS ™ tracheostomy tubes will now be included in the company’s standard product offering.
Sign-up for 2014/2/10 - Smiths Medical Launches MR Conditional Wire-reinforced Silicone Tracheostomy Tubes for Neonates and Pediatric Patients investment picks
2014/2/10
TROY, Mich.
Sign-up for 2014/2/10 - Meritor Announces Offering of $225 Million of Senior Unsecured Notes investment picks
2014/2/10
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that a publication in Nature Immunology demonstrates the scientific rationale for FAK inhibition in B cell-ALL.
Sign-up for 2014/2/10 - Nature Immunology Paper Highlights Potential Role of FAK Inhibition in Hematological Malignancies investment picks
2014/2/10
Perseus Books Group Tapped for Sales and Distribution of Titles Based on Beloved DreamWorks Characters and Franchises GLENDALE, Calif.
Sign-up for 2014/2/10 - DreamWorks Animation Begins a New Chapter with the Launch Of Dreamworks Press investment picks
2014/2/10
Demandware ®, Inc. (NYSE: DWRE), the industry-leading provider of enterprise cloud commerce solutions, today announced that it is presenting at the following investor conference: Goldman Sachs Technology & Internet Conference Scott Dussault, Demandware Chief Financial Officer, will present on Wednesday, February 12 at 3:20 pm PST at the Palace Hotel, 2 New Montgomery Street, San Francisco, California About Demandware Demandware, a leader in digital commerce, enables the world’s premier retailers to move faster and grow faster in the changing face of retail.
Sign-up for 2014/2/10 - Demandware to Present at Upcoming Investor Conference investment picks
2014/2/10
BEIJING , Feb.
Sign-up for 2014/2/10 - SouFun Announces Fourth Quarter and Fiscal Year 2013 Results investment picks
2014/2/10
Longview Announces Receipt of Unsolicited Non-Binding Proposal, Formation of a Special Committee and Directors Approval of Shareholder Rights Plan Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S./ (TSX: LNV) CALGARY , Feb.
Sign-up for 2014/2/10 - Longview Announces Receipt of Unsolicited Non-Binding Proposal, Formation of a Special Committee and Directors Approval of Shareholder Rights Plan investment picks
2014/2/10
Clean Energy Fuels Corp.
Sign-up for 2014/2/10 - Clean Energy Fuels to Provide Update of Natural Gas for the Trucking Industry at 9:00 AM ET / 6:00 AM PT investment picks
2014/2/10
NEW YORK , Feb.
Sign-up for 2014/2/10 - Faruqi & Faruqi Announces Filing Of Class Action Lawsuit Against Nicholas Financial, Inc. investment picks
2014/2/10
Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the fourth quarter and full-year ended December 31, 2013, including the following highlights: For the quarter ended December 31, 2013, the company reported consolidated quarterly revenues of $2.32 billion, an increase of 1.1% when compared to the fourth quarter of 2012.
Sign-up for 2014/2/10 - Owens & Minor Reports 4th Quarter & Full-Year 2013 Financial Results investment picks
2014/2/10
EL PASO, Texas, Feb.
Sign-up for 2014/2/10 - Western Refining to Participate in the Credit Suisse 19th Annual Energy Summit investment picks
2014/2/10
By Myra P.
Sign-up for 2014/2/10 - Rackspace drops, Urban Outfitters slips after hours investment picks
2014/2/10
Exelixis, Inc. (NASDAQ: EXEL) will release its fourth quarter and full year 2013 financial results on Thursday, February 20, 2014 after the markets close.
Sign-up for 2014/2/10 - Exelixis Announces February 20th Webcast of Fourth Quarter and Full Year 2013 Financial Results Conference Call investment picks
2014/2/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0926668001&sourceType=1 http://www.ccnmatthews.com/logos/20080605-TKLOGO2.JPG HAMILTON, BERMUDA --
Sign-up for 2014/2/10 - Teekay Offshore Partners Announces Fourth Quarter and Fiscal 2013 Earnings Results Conference Call investment picks
2014/2/10
CHATSWORTH, Calif., Feb.
Sign-up for 2014/2/10 - Capstone Turbine Announces Third Quarter Fiscal Year 2014 Operating Results investment picks
2014/2/10
SOUTH PLAINFIELD, N.J. , Feb.
Sign-up for 2014/2/10 - PTC Therapeutics Announces Proposed Public Offering of Common Stock investment picks
2014/2/10
Molina Healthcare, Inc. (NYSE: MOH): Full year 2013 net income per diluted share, continuing operations increased to $0.96, from $0.27 for 2012.
Sign-up for 2014/2/10 - Molina Healthcare Reports Fourth Quarter and Year-End 2013 Results investment picks
2014/2/10
C. R.
Sign-up for 2014/2/10 - Bard to Present at Citi 2014 Global Healthcare Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: 2014/2/10 - Sarepta Therapeutics Announces Positive Safety Results from Phase I Clinical Study of Marburg Drug Candidate to 2014/2/10 - Bard to Present at Citi 2014 Global Healthcare Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity